| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.081 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.086 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.6 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.082 | 0.6 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.075 | 0.6 |